ILIAS BIOLOGICS
ILIAS Biologics is a biotechnology company that specializes in therapeutic molecules. The company features platform technology that enables experts to load large therapeutic molecules into exosomes. ILIAS Biologics is developing various therapeutic exosomes, a potential treatment for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.
ILIAS BIOLOGICS
Industry:
Biopharma Biotechnology Medical Device
Founded:
2015-11-02
Address:
Daejeon, Taejon-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.iliasbio.com
Total Employee:
11+
Status:
Active
Contact:
(+82) 042.863.4450
Email Addresses:
[email protected]
Total Funding:
37.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache Mobile Non Scaleable Content Euro Cloudflare JS CDN JS Sectigo SSL Sectigo Domain SSL Naver Analytics
Similar Organizations
Current Employees Featured
Founder
Investors List
Meritz Securities
Meritz Securities investment in Series B - ILIAS Biologics
Asset One
Asset One investment in Series B - ILIAS Biologics
Time Folio Asset Management
Time Folio Asset Management investment in Series B - ILIAS Biologics
HB Investment
HB Investment investment in Series B - ILIAS Biologics
Daishin Securities
Daishin Securities investment in Series B - ILIAS Biologics
Hanyang Securities
Hanyang Securities investment in Series B - ILIAS Biologics
Genie Asset Management
Genie Asset Management investment in Series B - ILIAS Biologics
Daedeok Venture Partners
Daedeok Venture Partners investment in Series B - ILIAS Biologics
Kiwoom Investment
Kiwoom Investment investment in Series B - ILIAS Biologics
Devsisters Ventures
Devsisters Ventures investment in Series B - ILIAS Biologics
Official Site Inspections
http://www.iliasbio.com
- Host name: 211.47.74.39
- IP address: 211.47.74.39
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "ILIAS Biologics"
ILIAS Biologics
BioTV, the YouTube channel of Korea BIO(Korea Biotechnology Industry Organization) recently featured our co-CEO in their special interview series to introduce promising Korean bio start โฆSee details»
ILIAS Biologics - Crunchbase Company Profile & Funding
Organization. ILIAS Biologics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email โฆSee details»
ILIAS Biologics Inc. - LinkedIn
Dr. Chulhee Choi, CEO of ILIAS Biologics Inc., will participate as a workshop chair and expert speaker at the 6th Exosome-Based Therapeutic Development Summit, held in Boston, USA, from September ...See details»
ILIAS Biologics Inc. - Org Chart, Teams, Culture & Jobs - The Org
View ILIAS Biologics Inc.'s up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
ILIAS Biologics: Revenue, Worth, Valuation & Competitors 2024
About ILIAS Biologics. ILIAS Biologics is a Biotech related company founded in 2015 with an estimated revenue of $4.2M, and 27 employees. It has 10 competitors including Dermavant โฆSee details»
ILIAS Biologics Company Profile - Office Locations, Competitors
ILIAS Biologics is a biotechnology company of exosome therapeutics. Its platform, EXPLOR, makes it possible to load large therapeutic molecules into exosomes and then develop various โฆSee details»
Ilias Biologics (South Korea) Funding: $37.6M
Mar 11, 2025 Ilias Biologics is developing various therapeutic exosomes, a potential treatment for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic...See details»
ILIAS Biologics - Overview, News & Similar companies - ZoomInfo
Jun 28, 2021 ILIAS Biologics contact info: Phone number: +82 428634450 Website: www.iliasbio.com What does ILIAS Biologics do? ILIAS Biologics Inc. (previously Cellex Life โฆSee details»
ILIAS Biologics - VentureRadar
"At ILIAS Biologics, we dedicate ourselves to the development of paradigm-shifting advances in human medicine. Exosomes, extracellular vesicles naturally released by cells, represent such โฆSee details»
ILIAS Biologics, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore ILIAS Biologics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 2 news, and 23 literature, Disease Domain:Nervous System Diseases, Endocrinology and โฆSee details»
ILIAS Biologics Inc. Overview | SignalHire Company Profile
Phone Number: 82-042-863-4450: ILIAS Biologics Inc. industries Biotech, Biotechnology: Headquarters LocationSee details»
ILIAS Biologics - Company Profile - Tracxn
Feb 17, 2025 ILIAS Biologics - Developer of exosome based therapeutics. Raised a total funding of $40.2M over 1 round from 16 investors. Founded by Chulhee Choi in the year 2015. ILIAS โฆSee details»
ILIAS Biologics Inc. - LinkedIn
ILIAS Biologics Inc. | LinkedIn ํ๋ก์ 885๋ช | The Global Leader in Exosome-based Therapeutics | At ILIAS Biologics, we dedicate ourselves to the paradigm-shifting advances in human โฆSee details»
ILIAS Biologics - PitchBook
ILIAS Biologics General Information Description. Developer of an exosome-based therapeutics designed to bring technological innovation to drug development. The company develops novel โฆSee details»
ILIAS Biologics Company Information - Funding, Investors, and More
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
Exosome therapeutics Harnessing the Power of Exosomes - ILIAS Bio
For more information, visit iliasbio.com What area that youโre not already in could you see your technology making the biggest impact? Despite the tremendous impact of biological drugs that โฆSee details»
Ilias biologics inc. - Email Address & Phone Number - Lusha
Www.iliasbio.com At ILIAS Biologics, we dedicate ourselves to the paradigm-shifting advances in human medicine. We are specialized in developing engineered exosomes by loading large โฆSee details»
ILIAS Biologics Closes $20.6 Million Series B Financing - PR Newswire
DAEJEON, South Korea, Sept. 28, 2020 /PRNewswire/ -- ILIAS Biologics Inc. (the "Company" or "ILIAS"), a leading exosome-based therapeutics company, announced today that the โฆSee details»
ILIAS Biologics Inc. Receives HREC Approval to Initiate First-in โฆ
SEOUL, South Korea, April 7, 2022 /PRNewswire/ -- ILIAS Biologics Inc., a biotech company dedicated to developing a new treatment modality, engineered exosome therapeutics, โฆSee details»
ILIAS Biologics Inc. demonstrated the therapeutic effect of anti ...
Jun 28, 2021 ILIAS Research team and Yonsei University research team, led by professor of internal medicine Tae-Hyun Yoo and professor of oral pathology Jong In Yook, published the โฆSee details»